Par Drugs and Chemicals share news and announcements
Last close ₹103.43down ₹1.17 (1.12%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹104.60.
52-week range of traded prices to 23 Oct 2026
₹78.05Low, 30 Mar 2026₹180.00High, 3 Sep 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Next results date: the board meets on 29 Oct 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹127 Cr2,825th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 8 Aug 2026
- 8.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 May 2026
- 1.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 8 Aug 2026
- 13.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 8 Aug 2026
- 14.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day.
- 17,979
Par Drugs and Chemicals share news and announcements
367 announcements, routine notices left out, newest first. Page 6 of 8.
Nov 2021
Oct 2021
15 Oct · Analysts
5 Oct · Analysts
Sep 2021
30 Sep · Legal
The exchange asked on 29 Sep 2021
15 Sep · Updates
Aug 2021
24 Aug · Board meeting
16 Aug · Board meeting
Jul 2021
Jun 2021
15 Jun · Meeting
14 Jun · Legal
Exchange has sought clarification from Par Drugs And Chemicals Limited with respect to announcement dated 10-Jun-2021, regarding starting a new product line facility. On basis of above the Company is required to clarify following: 1. Name of the product;2. Date of launch;3. Category of the product;4. Whether caters to domestic/ international market;5. Name of the countries in which the product is launched (in case of international).The response of the Company is awaited.12 Jun · Updates
10 Jun · Board meeting
May 2021
Apr 2021
30 Apr · Board meeting
27 Apr · Board meeting
16 Apr · Updates
15 Apr · Corporate action
15 Apr · Amendment to AOA/MOA
15 Apr · Corporate action
Mar 2021
18 Mar · Amendment to AOA/MOA